Clinical Trial Update: Population-Based Modeling of Cholesterol Lowering in the United States

View source ↗

Summary

A completed population-based modeling study assessing how cholesterol-lowering strategies may impact cardiovascular risk in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Heart Disease
• Hypercholesterolemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Heart Disease Risk Reduction | Status: COMPLETED